Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Form 8.5 (EPT/RI)-Apax Global Alpha Limited

13 Aug 2025 08:52

Form 8.5 (EPT/RI)-Apax Global Alpha Limited

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeApax Global Alpha Limited
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Broker to Apax Global Alpha Limited
(d) Date dealing undertaken:12th August 2025
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
OrdinaryPurchases227,279163.3162.6
OrdinarySales385,251163.4162.8

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/AN/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/AN/AN/A

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:13th August 2025
Contact name:Priyali Bhattacharjee
Telephone number:+91-9768034903

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
2nd Mar 20237:00 amRNS2022 Final Results
2nd Feb 20237:00 amRNSApax Funds’ Valuations and Credit Facility update
2nd Feb 20237:00 amRNSThe Apax Digital Fund II invests in Magaya
24th Jan 202310:15 amEQSHardman & Co Q&A on Apax Global Alpha (APAX): Adding value to private companies
13th Jan 202311:10 amEQSHardman & Co Research on Apax Global Alpha (Initiation of coverage): Making pearls out of oysters
13th Jan 20237:00 amRNSDuck Creek Technologies to be acquired by Vista
10th Nov 20227:00 amRNSApax IX sells stake in Kepro
4th Nov 20227:00 amRNSQuarterly Results for 30 September 2022
22nd Sep 20227:00 amRNSApax IX agrees to sell stake in Authority Brands
14th Sep 20227:00 amRNSThe Apax Digital Fund II invests in Xeneta
19th Aug 20227:00 amRNS2022 Interim Dividend
19th Aug 20227:00 amRNS2022 Interim Report and Accounts
19th Aug 20227:00 amRNS2022 Interim Results Highlights
5th Aug 20227:00 amRNSApax Funds’ Valuations as at 30 June 2022
26th Jul 20227:00 amRNSFunds advised by Apax to acquire Pickles Auctions
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSProposed commitment to Apax XI
17th Jun 20227:00 amRNSDirector Declaration - Additional Directorship
10th Jun 20227:00 amRNSFunds Advised by Apax Sell Stake in MyCase
7th Jun 20227:00 amRNSFunds advised by Apax to acquire EcoOnline
13th May 20224:02 pmRNSDirector/PDMR Shareholding
12th May 20227:00 amRNSDirector/PDMR Shareholding
6th May 20227:00 amRNSResult of AGM
6th May 20227:00 amRNSIncrease to the Revolving Credit Facility
6th May 20227:00 amRNSQuarterly results for 31 March 2022
7th Apr 20227:00 amRNSProposed commitment to AMI Opportunities Fund II
22nd Mar 20227:00 amRNSApax Digital Funds invest in ClearBank
17th Mar 20223:59 pmRNSPurchase of Ordinary Shares under IM Agreement
8th Mar 20227:00 amRNSProposed commitment to Apax Global Impact Fund
2nd Mar 20227:00 amRNSKey Information Document
2nd Mar 20227:00 amRNS2021 Annual Dividend Declaration
2nd Mar 20227:00 amRNSNotice of AGM
2nd Mar 20227:00 amRNS2021 Annual Report and Accounts
2nd Mar 20227:00 amRNS2021 Final Results
14th Feb 20227:00 amRNSApax X invests in Alcumus and Ole Smoky
3rd Feb 20227:00 amRNSApax Funds’ Valuations as at 31 December 2021
31st Jan 20224:36 pmRNSPrice Monitoring Extension
23rd Dec 202110:30 amRNSDirector Declaration
17th Dec 20219:30 amRNSDirector Declaration
6th Dec 20217:00 amRNSFunds advised by Apax sell stakes in Unilabs
9th Nov 20217:00 amRNSInmarsat agrees combination with Viasat
4th Nov 20217:00 amRNSQuarterly results for 30 September 2021
2nd Nov 20217:00 amRNSFunds advised by Apax announce investment in Lever
1st Nov 20217:00 amRNSApax Funds to acquire HSG
6th Oct 20217:00 amRNSApax Funds to acquire Eating Recovery Center
16th Sep 20217:00 amRNSInitial Public Offering of Thoughtworks
8th Sep 20217:00 amRNSFunds advised by Apax to invest in T-Mobile
2nd Sep 20217:00 amRNSWizeline Acquired by CDPQ
1st Sep 20217:00 amRNSFunds advised by Apax to acquire SavATree
31st Aug 20215:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.